For the Inventor, By the Inventor

Enter assignee name

Spring, TX, United States of America

Io Therapeutics, Inc.

USPTO Granted Patents = 72

CIPO Patents = 4

EPO Patents = 7

Forward Citations = 441

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Roshantha A Chandraratna (63 out of 291 patents)

Martin E Sanders (49 out of 51 patents)

Randolph J Noelle (11 out of 66 patents)

4. Ethan Dmitrovsky (11 out of 21 patents)

5. Elizabeth Nowak (11 out of 18 patents)

6. Vidyasagar Pradeep Vuligonda (7 out of 86 patents)

7. Powel H Brown (4 out of 4 patents)

8. Andrew S Thompson (2 out of 75 patents)

9. Gabriel Ghiaur (2 out of 2 patents)

10. Thomas Jacks (2 out of 2 patents)

11. Peter Wade (2 out of 2 patents)

12. Richard John Jones (2 out of 8 patents)

13. Shanming Kuang (2 out of 2 patents)

14. Harsh Shailesh Shah (2 out of 2 patents)

15. Cassandra Moyer (2 out of 2 patents)

Core Competencies:

RXR Agonists

Cancer Treatment

Autoimmune Disorders

Immunomodulatory Effects

Nervous System Disorders

Retinoid Compounds

RAR Agonists

Thyroid Hormones

Drug Resistant Cancers

Polymorphs

Cancer Immunotherapy

Synthetic Methods

72 patents: Sort by Forward Citations

1. 12383521 - Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists (2025-08-12),

2. 12325685 - RXR agonist salt form, polymorphs thereof, and uses thereof (2025-06-10),

3. 12115193 - Methods of using RARγ agonists for cancer treatment (2024-10-15),

4. 11998521 - Use of an RXR agonist in treating drug resistant HER2+ cancers (2024-06-04),

5. 11976021 - Synthesis of tetrahydronaphthalenols and uses thereof (2024-05-07),

6. 11919848 - RXR agonist salt form, polymorphs thereof, and uses thereof (2024-03-05),

7. 11896558 - Use of an RXR agonist and taxanes in treating Her2+ cancers (2024-02-13),

8. 11793835 - Methods of using RARγ agonists for cancer treatment (2023-10-24),

9. 11793781 - Autoimmune disorder treatment using RXR agonists (2023-10-24),

10. 11786555 - RAR selective agonists in combination with immune modulators for cancer immunotherapy (2023-10-17),

11. 11779558 - Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy (2023-10-10),

12. 11737996 - Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy (2023-08-29),

13. 11690832 - Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones (2023-07-04),

14. 11690831 - Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones (2023-07-04),

15. 11648223 - Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy (2023-05-16),

Io Therapeutics, Inc. is a biopharmaceutical company focused on the development of innovative treatments for various diseases. Our mission is to enhance the lives of patients by advancing therapeutic options through cutting-edge research and development. With a strong emphasis on precision medicine, we strive to deliver targeted therapies that address unmet medical needs. Our team of experienced scientists and researchers work tirelessly to identify novel drug candidates and conduct rigorous clinical trials. Io Therapeutics is committed to making a positive impact in the field of healthcare. Visit our website to learn more about our current projects and corporate initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

72 Patents

#4 in Spring, TX

#285 in Texas

#4,879 in US

#9,952 in the World

Spring, TX, United States of America

Io Therapeutics, Inc.

Forward Citations = 441

19 inventors:

Roshantha A Chandraratna (63 out of 291 patents)

Martin E Sanders (49 out of 51 patents)

Randolph J Noelle (11 out of 66 patents)

4. Ethan Dmitrovsky (11 out of 21 patents)

5. Elizabeth Nowak (11 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…